Sharon F. Freedman, MD ...

Dr. Sharon F Freedman, MD

Claim this profile

Duke University Eye Center

Studies Retinopathy of Prematurity
Studies Cystoid Macular Edema
5 reported clinical trials
7 drugs studied

Area of expertise

1Retinopathy Of Prematurity
Sharon F Freedman, MD has run 4 trials for Retinopathy of Prematurity. Some of their research focus areas include:
Stage II
Stage III
2Cystoid Macular Edema
Sharon F Freedman, MD has run 1 trial for Cystoid Macular Edema.

Affiliated Hospitals

Image of trial facility.
Duke University Eye Center

Clinical Trials Sharon F Freedman, MD is currently running

Image of trial facility.

OCT Imaging Systems

for Retinal Disease in Children

Handheld optical coherence tomography (OCT) has become an important imaging modality to evaluate the pediatric retina. The objective of this pilot study is to compare a new contact OCT system (Theia Imaging) with an investigational noncontact OCT system (Duke Biomedical Engineering) to assess their ability to image the pediatric retina. The investigators hypothesize that the contact OCT system is superior in imaging larger areas of the retina (larger field-of-view), while it has similar resolution to image the retina substructures (non-inferior image quality).
Recruiting1 award N/A8 criteria
Image of trial facility.

High-Speed Eye Scanning Technology

for Retinopathy of Prematurity

Retinopathy of prematurity (ROP) is a disorder of development of the neural retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. This study tests high-speed optical coherence tomography (OCT) technology compared to conventional color photographs at the bedside of very preterm infants in the intensive care nursery, to characterize previously unseen abnormalities that can predict a need for referral for ROP treatment, or poor visual or neurological development later in life, up to pre-school age. Our long-term goal is to help improve preterm infant health and vision via objective bedside imaging and analysis that characterizes early critical indicators of ROP, and poor visual function and neurological development, which will rapidly translate to better early intervention and improved future care.
Recruiting1 award N/A

More about Sharon F Freedman, MD

Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sharon F Freedman, MD has experience with
  • Bevacizumab
  • Laser
  • Swept Source OCT
  • Investigational Ultracompact OCT And OCTA System
  • Retinal Photographs
  • Investigational Contact OCT System

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Sharon F Freedman, MD specialize in?
Is Sharon F Freedman, MD currently recruiting for clinical trials?
Are there any treatments that Sharon F Freedman, MD has studied deeply?
What is the best way to schedule an appointment with Sharon F Freedman, MD?
What is the office address of Sharon F Freedman, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security